SCHEMBL21972872

SCHEMBL21972872

Cc1ccccc1N(c1ccc2ccc3c(N(c4ccccc4C)c4cc5ccccc5c5c4oc4c(C6CCCCC6)cccc45)ccc4ccc1c2c43)c1cc2ccccc2c2c1oc1c(C3CCCCC3)cccc12

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21904610 0.90 CYP1B1 (0.35) CYP1B1
SCHEMBL16216705 0.88 CYP1B1 (0.33) CYP1B1
SCHEMBL21972165 0.88 CYP1B1 (0.36) CYP1B1
SCHEMBL16216427 0.87 CYP1B1 (0.32) CYP1B1
SCHEMBL20169017 0.86 CYP1B1 (0.32) CYP1B1
SCHEMBL21972167 0.86 CYP1B1 (0.32) CYP1B1
SCHEMBL21972183 0.84 CYP1B1 (0.30) CYP1B1
SCHEMBL21972417 0.83 CYP1B1 (0.34) CYP1B1
SCHEMBL16216708 0.82 CASP3 (0.32) CYP1B1
SCHEMBL21972873 0.82 CYP1B1 (0.39) CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150988-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-05-18 US disclosed
US-20230150988-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-05-18 US disclosed
US-20200140422-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140422-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device CYP1A1, CYP1B1, CHRM1 CYP1B1 2/4885
US-20230150988-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device CYP1A1, CYP1B1, CHRM1 CYP1B1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.